Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Vestibular Ocular Motor Screening Tool (VOMS)
United Therapeutics Europe Ltd
Mild Traumatic Brain Injury
1 trial -
Vildagliptin 50 mg bid
The First People's Hospital of Lianyungang
Parkinson's Disease
1 trial -
Village doctor-led tailored health management
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
Vitaflow Preload
United Therapeutics Europe Ltd
Starvation
1 trial -
Vitamin C
The First People's Hospital of Lianyungang
Ageing
1 trial -
Vitamin D
The First People's Hospital of Lianyungang
Development, Child
1 trial -
Vitamin D and calcium
United Therapeutics Europe Ltd
Vitamin D Deficiency
1 trial -
Vitamin K
United Therapeutics Europe Ltd
Calciphylaxis
1 trial -
Vitamins and Minerals
United Therapeutics Europe Ltd
Complications of Other Bariatric Procedure
1 trial -
Voglibose tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Western therapy
Chinese University of Hong Kong
Hand, Foot and Mouth Disease
1 trial -
Wheat Soy Blend Plus Plus (WSB++) with nutrition counselling
United Therapeutics Europe Ltd
Moderate Acute Malnutrition
1 trial -
Whey Protein
United Therapeutics Europe Ltd
High Blood Pressure
1 trial -
Whole Body Non-Contrast MRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Whole exome sequencing
United Therapeutics Europe Ltd
Healthy Adults
1 trial -
Whole peanuts without skins, Peanut butter, or no peanuts (control)
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
Wild blueberry containing foods
United Therapeutics Europe Ltd
Healthy
1 trial -
Window of Implantation
Inhibitor Therapeutics
IVF
1 trial -
Wobenzym PS
Atrium Therapeutics
Sub-clinical Inflammation
1 trial -
Xuebi formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Peripheral Neuropathy
1 trial -
Yishen Qutong Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources